Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Resorcinol study

This article was originally published in The Tan Sheet

Executive Summary

HHS National Toxicology Program's recently released report on resorcinol concludes that there is "no evidence of carcinogenic activity in male F344/N rats given 50, 100, or 150 mg/kg" of resorcinol, and "no evidence of carcinogenic activity of resorcinol in male or female B6C3F[1] mice given 112 or 225 mg/kg" resorcinol. Resorcinol is the active ingredient in Menley & James' Acnomel Cream and Sandoz' BiCozene Creme. The ingredient was studied by NTP because of its potential for "consumer exposure and the absence of data on the effects of long- term exposure".
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel